Related Experiment Video
Updated: May 27, 2026
09:16
Analyzing Craniofacial Morphogenesis in Zebrafish Using 4D Confocal Microscopy
Published on: January 30, 2014
Twist controls skeletal development and dorsoventral patterning by regulating runx2 in zebrafish
Der-Chih Yang1, Chih-Chien Tsai, Yun-Feng Liao
1Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Plos One
|November 17, 2011
Summary
Twist1a and Twist1b proteins are crucial for zebrafish skeletal development and body patterning. Their regulation of runx2b influences these processes, offering potential therapeutic targets for skeletal disorders.
Area of Science:
- Developmental Biology
- Genetics
- Molecular Biology
Background:
- Twist1a and Twist1b are key regulators of cellular signaling pathways.
- Runx2 expression is vital for skeletal development and embryonic patterning.
- The precise roles of Twist proteins and maternal Runx2 in zebrafish embryogenesis are not fully understood.
Purpose of the Study:
- To investigate the function of Twist1a and Twist1b in zebrafish skeletal development and dorsoventral patterning.
- To elucidate the relationship between Twist proteins and Runx2b in early embryonic development.
Main Methods:
- Morpholino-induced knockdown of twist genes in zebrafish embryos.
- Overexpression studies using mRNA injection of twist1a and twist1b.
- Analysis of skeletal development and dorsoventral patterning.
- Quantitative analysis of runx2b expression levels.
Main Results:
- Twist1a and Twist1b are essential for proper skeletal formation and dorsoventral patterning.
- Loss of Twist1a/1b function resulted in enhanced skeletal formation and ventralized embryos.
- Gain of Twist1a/1b function led to impaired skeletal development and dorsalized embryos.
- Twist1a/1b regulate runx2b expression, and runx2b knockdown rescues Twist1a/1b knockdown phenotypes.
Conclusions:
- Twist1a and Twist1b are critical regulators of skeletal development and dorsoventral patterning in zebrafish, acting through the modulation of runx2b.
- These findings identify Twist1a/1b and runx2b as potential therapeutic targets for skeletal development disorders.
